Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

23andMe

23andMe
2006 FOUNDED
PRIVATE STATUS
301-400 EMPLOYEES
Corporate LATEST DEAL TYPE
$300M LATEST DEAL AMOUNT
42 INVESTORS
Description

Operator of a consumer genetics and research platform designed to help people access, understand and benefit from the human genome. The company's consumer genetics and research platform provides web-based interactive tools for individuals to learn and explore their own genetic information through DNA analysis technologies, enabling patients to gain deeper insights into personal ancestry, genealogy and inherited traits.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 899 West Evelyn Avenue
  • Mountain View, CA 94041
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 23andMe’s full profile, request a free trial.

23andMe Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Corporate 25-Jul-2018 $300M 00000 00.00 Completed Generating Revenue
12. Later Stage VC 01-Jan-2018 00000 Completed Generating Revenue
11. Secondary Transaction - Private 22-Dec-2017 00000 Completed Generating Revenue
10. Later Stage VC (Series F) 12-Sep-2017 00000 00000 00.000 Completed Generating Revenue
9. Later Stage VC 00.000 00000 Completed Generating Revenue
8. Grant 13-Oct-2016 00.00 00000 Completed Generating Revenue
7. Grant 05-Apr-2016 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 14-Oct-2015 00000 00000 00.00 Completed Generating Revenue
5. Grant 29-Jul-2014 $1.37M $126M Completed Generating Revenue
4. Later Stage VC (Series D) 10-Dec-2012 $57.9M $126M 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

23andMe Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series F1 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 000
Series F 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.00
Series E 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 9,048,560 $0.000010 $0.18 $3.07 $3.07 1x $3.07 6.28%
Series A 7,119,936 $0.000010 $0.08 $1.26 $1.26 1x $1.26 4.94%
To view this company’s complete Cap Table, request access »

23andMe Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 13-Dec-2018 0000 00000 0000 Social/Platform Software
000000 00 000000 20-Jul-2015 00000 00000 00 0000 Information Services (B2C) 0000 00000000
CureTogether 10-Jul-2012 Merger/Acquisition Decision/Risk Analysis 0000 00000000
To view this company’s complete investment and acquisition history, request access »

23andMe Investors (42)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
GlaxoSmithKline Corporation Minority 000 0000 000000 0
Black River Ventures Venture Capital Minority 000 0000 000000 0
MicroVentures Venture Capital Minority 000 0000 000000 0
Newview Capital Venture Capital Minority 000 0000 000000 0
Revelation Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 42 investors. Get the full list »

23andMe Executive Team (38)

Name Title Board
Seat
Contact
Info
Anne Wojcicki Co-Founder, Chief Executive Officer & Board Member
Steve Schoch Chief Financial Officer
Kathy Hibbs JD Chief Legal & Regulatory Officer
Richard Scheller Ph.D Chief Scientific Officer & Head of Therapeutics
Michele Mieuli Director, Corporate & Business Development

20 Former Executives

You’re viewing 5 of 38 executives. Get the full list »

23andMe Board Members (7)

Name Representing Role Since Contact
Info
Anne Wojcicki 23andMe Co-Founder, Chief Executive Officer & Board Member 000 0000
Esther Dyson Self Board Member 000 0000
Neal Mohan 23andMe Board Member 000 0000
Patrick Chung JD Xfund Board Member 000 0000
Roelof Botha Sequoia Capital Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 7 board members. Get the full list »